 |
BioWorld-International-2004-08-11
Vernalis, Novartis Collaborate On Hsp90 Program In Cancer
Vernalis, Novartis Collaborate On Hsp90 Program In Cancer
LONDON - Vernalis plc completed a trilogy of deals, announcing an Hsp90 cancer research collaboration with the Novartis Institute for Biomedical Research to add to recent agreements with Biogen Idec Inc. and Endo Pharmaceuticals Inc. (BioWorld International)